iTeos Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
iTeos Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q2 2024.
  • iTeos Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -414 %, a 445% decline year-over-year.
  • iTeos Therapeutics, Inc. annual Operating Margin for 2023 was -1.2K %, a 2642% decline from 2022.
  • iTeos Therapeutics, Inc. annual Operating Margin for 2022 was 47.2 %, a 33.5% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -414 -338 -445% Apr 1, 2024 Jun 30, 2024
Q4 2023 -1.2K -1.25K -2642% Oct 1, 2023 Dec 31, 2023
Q3 2023 -141 Jul 1, 2023 Sep 30, 2023
Q2 2023 -76 Apr 1, 2023 Jun 30, 2023
Q1 2023 -15.2 Jan 1, 2023 Mar 31, 2023
Q4 2022 47.2 Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.